内镜下微血管减压术中岩静脉牺牲与否的并发症发生率均较低
该研究回顾了201例接受内镜下微血管减压术治疗三叉神经痛的患者,其中59%牺牲了岩静脉。岩静脉牺牲组与保留组的神经功能障碍发生率分别为1.69%和2.41%,无静脉性梗死、小脑肿胀或致命并发症。87.3%的患者术后1个月疼痛明显改善,两组无差异。
要点
- 201例内镜下微血管减压术中59%牺牲岩静脉,其中部分牺牲21%、完全牺牲37%。
- 岩静脉牺牲组非神经并发症1.69%,保留组0%;神经功能障碍两组分别为1.69%和2.41%。
- 术后1个月87.3%患者疼痛明显改善,岩静脉牺牲组与保留组无差异。
核心结论
- 本研究未发现内镜下微血管减压术治疗三叉神经痛时牺牲岩静脉的患者并发症发生率更高。
- 在本系列中岩静脉仅在59%的病例中被牺牲,该技术似乎是安全的,但需要更大规模的研究来确定岩静脉牺牲后并发症的真实发生率。
研究设计与样本
- 5年回顾性审查纳入201例因三叉神经痛接受内镜下微血管减压术的患者。
- 分析岩静脉牺牲情况、血管压迫解剖以及可归因于静脉功能不全的术后并发症,并分析术前和术后疼痛结局。
主要发现
- 201例患者中118例(59%)牺牲岩静脉,其中部分牺牲43例(21%),完全牺牲75例(37%)。
- 岩静脉牺牲组非神经并发症发生率为1.69%(2/118),岩静脉保留组为0%(0/83)。
- 神经功能障碍(面瘫、传导性听力损失、步态不稳、记忆障碍)在岩静脉保留组与牺牲组发生率分别为2.41%与1.69%。
- 总体87.3%(145/166)的患者在术后1个月报告疼痛「明显改善」或「大幅改善」,两组间未发现差异。
- 两个队列均未观察到静脉性梗死、小脑肿胀或致命并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更大规模的研究来确定岩静脉牺牲后并发症的真实发生率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endoscopic-microvascular decompression (E-MVD) is a well-described treatment for trigeminal neuralgia (TGN), but there has been debate on the safety of intraoperative sacrifice of the petrosal vein (PV) due to concern for subsequent venous insufficiency. Our objective was to investigate the risk of PV sacrifice during E-MVD in TGN and subsequent postoperative complications and pain outcomes. METHODS: 5 five-year review yielded 201 patients who underwent MVD for TGN. PV sacrifice, vascular compressive anatomy, and postoperative complications attributable to venous insufficiency were analyzed. Preoperative and postoperative pain outcomes were analyzed. RESULTS: PV was sacrificed in 118 of 201 (59%) of patients, with 43 of 201 (21%) patients undergoing partial sacrifice versus 75 of 201 (37%) with complete sacrifice. No cases of venous infarction, cerebellar swelling, or fatal complications were noted in either cohort. Non-neurologic complications occurred in 1.69% (2 of 118) of patients with PV sacrifice and 0% (0 of 83) of patients with PV preservation. Neurologic deficits (facial palsy, conductive hearing loss, gait instability, memory deficit) occurred in equal proportions in PV preservation and sacrifice groups (2.41% vs. 1.69%) Overall, 87.3% (145 of 166) patients reported their pain as "very much improved" or "much improved" at 1 month, and no difference between groups was identified. CONCLUSIONS: This study did not find higher complication rates in patients undergoing petrosal vein sacrifice during E-MVD for trigeminal neuralgia. In this series where petrosal vein was sacrificed only 59% of the time, it appears to be a safe technique, but larger studies will be needed to determine true incidence of complications after PV sacrifice.
引用
- Blue R, Li C, Spadola M, et al. Complication Rates During Endoscopic Microvascular Decompression Surgery Are Low With or Without Petrosal Vein Sacrifice. World Neurosurg. 2020. PMID: 32145425. doi:10.1016/j.wneu.2020.02.142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。